Skip to main content
Top
Published in: Neurological Sciences 11/2016

01-11-2016 | Original Article

Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure

Authors: Giorgia Querin, Elisa DaRe, Ilaria Martinelli, Luca Bello, Cinzia Bertolin, Davide Pareyson, Caterina Mariotti, Elena Pegoraro, Gianni Sorarù

Published in: Neurological Sciences | Issue 11/2016

Login to get access

Abstract

The Spinal and Bulbar Muscular Atrophy Functional Rating Scale (SBMAFRS) is an established rating instrument used to assess the functional status of patients with Spinal and Bulbar Muscular Atrophy (SBMA). Our aim was to validate an Italian version of the scale. We administered the SBMAFRS to sixty SBMA patients during routine follow-up of clinical evaluations. To estimate the test stability, the scale was re-administered to a subset of 39 randomly selected patients after 8 weeks. The patients underwent clinical evaluation including 6-min walk. Psychometric analysis included reliability assessment and factorial analysis. To evaluate convergent validity, correlations between SBMAFRS items and muscular force assessed by manual testing, ALSFRS total score and subscales scores, and forced vital capacity, were performed. Internal consistency as measured by Cronbach’s alpha (total scale 0.85) was high. Test–retest reliability assessed by Spearman’s rho was also high. Principal component analysis with varimax rotation yielded a four-factor solution accounting for approximately 79 % of the variance. The scale total score and subscales score were strongly correlated with respective items and subscores of the ALSFRS, with respiratory function and with the 6-min walk test. In conclusion, we performed an Italian validation of the only existing disease-specific Functional Rating Scale for SBMA patients. This scale will be a useful tool not only in the clinical practice but also as an outcome measure in upcoming clinical trials.
Literature
1.
go back to reference Kennedy WR, Alter M, Sung JH (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait. Neurology 18:671–680CrossRefPubMed Kennedy WR, Alter M, Sung JH (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait. Neurology 18:671–680CrossRefPubMed
3.
go back to reference Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A (1989) X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112:209–232CrossRefPubMed Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A (1989) X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112:209–232CrossRefPubMed
5.
go back to reference La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor mutation in X-linked spinal and bulbar muscular atrophy. Nature 352:77–79CrossRefPubMed La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor mutation in X-linked spinal and bulbar muscular atrophy. Nature 352:77–79CrossRefPubMed
6.
go back to reference Nedelsky NB, Pennuto M, Smith RB, Palazzolo I, Moore J, Nie Z, Neale G, Taylor JP (2010) Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron 23:936–952. doi:10.1016/j.neuron.2010.08.034 CrossRef Nedelsky NB, Pennuto M, Smith RB, Palazzolo I, Moore J, Nie Z, Neale G, Taylor JP (2010) Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron 23:936–952. doi:10.​1016/​j.​neuron.​2010.​08.​034 CrossRef
7.
8.
go back to reference Hanajima R, Terao Y, Nakatani-Enomoto S, Hamada M, Yugeta A, Matsumoto H, Yamamoto T, Tsuji S, Ugawa Y (2009) Postural tremor in X-linked spinal and bulbar muscular atrophy. Mov Disord 24:2063–2069. doi:10.1002/mds.22566 CrossRefPubMed Hanajima R, Terao Y, Nakatani-Enomoto S, Hamada M, Yugeta A, Matsumoto H, Yamamoto T, Tsuji S, Ugawa Y (2009) Postural tremor in X-linked spinal and bulbar muscular atrophy. Mov Disord 24:2063–2069. doi:10.​1002/​mds.​22566 CrossRefPubMed
9.
go back to reference Sperfeld AD, Karitzky J, Brummer D, Schreiber H, Häussler J, Ludolph AC, Hanemann CO (2002) X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol 59:1921–1926CrossRefPubMed Sperfeld AD, Karitzky J, Brummer D, Schreiber H, Häussler J, Ludolph AC, Hanemann CO (2002) X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol 59:1921–1926CrossRefPubMed
10.
go back to reference Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M, Tanaka F, Tamakoshi A, Sobue G (2006) Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 129:1446–1455CrossRefPubMed Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M, Tanaka F, Tamakoshi A, Sobue G (2006) Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 129:1446–1455CrossRefPubMed
13.
go back to reference Hashizume A, Katsuno M, Banno H et al (2012) Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Brain 135:2838–2848CrossRefPubMed Hashizume A, Katsuno M, Banno H et al (2012) Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Brain 135:2838–2848CrossRefPubMed
14.
go back to reference Querin G, D’Ascenzo C, Peterle E, Ermani M, Bello L, Melacini P, Morandi L, Mazzini L, Silani V, Raimondi M, Mandrioli J, Romito S, Angelini C, Pegoraro E, Sorarù G (2013) Pilot trial of clenbuterol in spinal and bulbar muscular atrophy. Neurology 80:2095–2098CrossRefPubMed Querin G, D’Ascenzo C, Peterle E, Ermani M, Bello L, Melacini P, Morandi L, Mazzini L, Silani V, Raimondi M, Mandrioli J, Romito S, Angelini C, Pegoraro E, Sorarù G (2013) Pilot trial of clenbuterol in spinal and bulbar muscular atrophy. Neurology 80:2095–2098CrossRefPubMed
15.
go back to reference Banno H, Katsuno M, Suzuki K, Takeuchi Y, Kawashima M, Suga N, Takamori M, Ito M, Nakamura T, Matsuo K, Yamada S, Oki Y, Adachi H, Minamiyama M, Waza M, Atsuta N, Watanabe H, Fujimoto Y, Nakashima T, Tanaka F, Doyu M, Sobue G (2009) Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol 65:140–150. doi:10.1002/ana.21540 CrossRefPubMed Banno H, Katsuno M, Suzuki K, Takeuchi Y, Kawashima M, Suga N, Takamori M, Ito M, Nakamura T, Matsuo K, Yamada S, Oki Y, Adachi H, Minamiyama M, Waza M, Atsuta N, Watanabe H, Fujimoto Y, Nakashima T, Tanaka F, Doyu M, Sobue G (2009) Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol 65:140–150. doi:10.​1002/​ana.​21540 CrossRefPubMed
16.
go back to reference Fernandez-Rhodes LE, Kokkinis AD, White MJ, Watts CA, Auh S, Jeffries NO, Shrader JA, Lehky TJ, Li L, Ryder JE, Levy EW, Solomon BI, Harris-Love MO, La Pean A, Schindler AB, Chen CJ, Di Prospero NA, Fischbeck KH (2011) Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol 10:140–147. doi:10.1016/S1474-4422(10)70321-5 CrossRefPubMedPubMedCentral Fernandez-Rhodes LE, Kokkinis AD, White MJ, Watts CA, Auh S, Jeffries NO, Shrader JA, Lehky TJ, Li L, Ryder JE, Levy EW, Solomon BI, Harris-Love MO, La Pean A, Schindler AB, Chen CJ, Di Prospero NA, Fischbeck KH (2011) Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol 10:140–147. doi:10.​1016/​S1474-4422(10)70321-5 CrossRefPubMedPubMedCentral
17.
go back to reference Shrader JA, Kats I, Kokkinis A, Zampieri C, Levy E, Joe GO, Woolstenhulme JG, Drinkard BE, Smith MR, Ching W, Ghosh L, Fox D, Auh S, Schindler AB, Fischbeck KH, Grunseich C (2015) A randomized controlled trial of exercise in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol 2:739–747. doi:10.1002/acn3.208 CrossRefPubMedPubMedCentral Shrader JA, Kats I, Kokkinis A, Zampieri C, Levy E, Joe GO, Woolstenhulme JG, Drinkard BE, Smith MR, Ching W, Ghosh L, Fox D, Auh S, Schindler AB, Fischbeck KH, Grunseich C (2015) A randomized controlled trial of exercise in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol 2:739–747. doi:10.​1002/​acn3.​208 CrossRefPubMedPubMedCentral
18.
go back to reference Weydt P, Sagnelli A, Rosenbohm A, Fratta P, Pradat PF, Ludolph AC, Pareyson D (2015) Clinical trials in spinal and bulbar muscular atrophy-past, present, and future. J Mol Neurosci. doi:10.1007/s12031015-0682-7 PubMed Weydt P, Sagnelli A, Rosenbohm A, Fratta P, Pradat PF, Ludolph AC, Pareyson D (2015) Clinical trials in spinal and bulbar muscular atrophy-past, present, and future. J Mol Neurosci. doi:10.​1007/​s12031015-0682-7 PubMed
19.
go back to reference Pennuto M, Greensmith L, Pradat PF, Sorarù G (2015) 210th ENMC International Workshop: Research and clinical management of patients with spinal and bulbar muscular atrophy, 27–29 March, 2015, Naarden, The Netherlands. Neuromuscul Disord 25:802–812. doi:10.1016/j.nmd.2015.06.462 CrossRefPubMed Pennuto M, Greensmith L, Pradat PF, Sorarù G (2015) 210th ENMC International Workshop: Research and clinical management of patients with spinal and bulbar muscular atrophy, 27–29 March, 2015, Naarden, The Netherlands. Neuromuscul Disord 25:802–812. doi:10.​1016/​j.​nmd.​2015.​06.​462 CrossRefPubMed
20.
go back to reference Mayhew A, Cano S, Scott E, Eagle M, Bushby K, Muntoni F (2011) North Star clinical network for paediatric neuromuscular disease. Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol 53:535–542. doi:10.1111/j.1469-8749.2011.03939.x CrossRefPubMed Mayhew A, Cano S, Scott E, Eagle M, Bushby K, Muntoni F (2011) North Star clinical network for paediatric neuromuscular disease. Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol 53:535–542. doi:10.​1111/​j.​1469-8749.​2011.​03939.​x CrossRefPubMed
21.
go back to reference Harris-Love MO, Fernandez-Rhodes L, Joe G, Shrader JA, Kokkinis A, La Pean Kirschner A, Auh S, Chen C, Li L, Levy E, Davenport TE, Di Prospero NA, Fischbeck KH (2014) Assessing function and endurance in adults with spinal and bulbar muscular atrophy: validity of the adult myopathy assessment tool. Rehabil Res Pract 2014:873872. doi:10.1155/2014/873872 PubMedPubMedCentral Harris-Love MO, Fernandez-Rhodes L, Joe G, Shrader JA, Kokkinis A, La Pean Kirschner A, Auh S, Chen C, Li L, Levy E, Davenport TE, Di Prospero NA, Fischbeck KH (2014) Assessing function and endurance in adults with spinal and bulbar muscular atrophy: validity of the adult myopathy assessment tool. Rehabil Res Pract 2014:873872. doi:10.​1155/​2014/​873872 PubMedPubMedCentral
22.
go back to reference Hobart JC, Cano SJ, Zajicek JP, Thompson AJ (2007) Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol 6:1094–1105CrossRefPubMed Hobart JC, Cano SJ, Zajicek JP, Thompson AJ (2007) Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol 6:1094–1105CrossRefPubMed
23.
go back to reference Takeuchi Y, Katsuno M, Banno H, Suzuki K, Kawashima M, Atsuta N, Ito M, Watanabe H, Tanaka F, Sobue G (2008) Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle Nerve 8:964–971CrossRef Takeuchi Y, Katsuno M, Banno H, Suzuki K, Kawashima M, Atsuta N, Ito M, Watanabe H, Tanaka F, Sobue G (2008) Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle Nerve 8:964–971CrossRef
24.
go back to reference Cederbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS Functional Rating Scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21CrossRef Cederbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS Functional Rating Scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21CrossRef
25.
go back to reference Hashizume A, Katsuno M, Suzuki K, Banno H, Suga N, Mano T, Araki A, Hijikata Y, Grunseich C, Kokkinis A, Hirakawa A, Watanabe H, Yamamoto M, Fischbeck KH, Sobue G (2015) A functional scale for spinal and bulbar muscular atrophy: cross-sectional and longitudinal study. Neuromuscul Disord 25:554–562. doi:10.1016/j.nmd.2015.03.008 CrossRefPubMed Hashizume A, Katsuno M, Suzuki K, Banno H, Suga N, Mano T, Araki A, Hijikata Y, Grunseich C, Kokkinis A, Hirakawa A, Watanabe H, Yamamoto M, Fischbeck KH, Sobue G (2015) A functional scale for spinal and bulbar muscular atrophy: cross-sectional and longitudinal study. Neuromuscul Disord 25:554–562. doi:10.​1016/​j.​nmd.​2015.​03.​008 CrossRefPubMed
26.
go back to reference Querin G, Bertolin C, Da Re E, Volpe M, Zara G, Pegoraro E, Caretta N, Foresta C, Silvano M, Corrado D, Iafrate M, Angelini L, Sartori L, Pennuto M, Gaiani A, Bello L, Semplicini C, Pareyson D, Silani V, Ermani M, Ferlin A, Sorarù G, Italian Study Group on Kennedy’s disease (2015) Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2015-311305 PubMedCentral Querin G, Bertolin C, Da Re E, Volpe M, Zara G, Pegoraro E, Caretta N, Foresta C, Silvano M, Corrado D, Iafrate M, Angelini L, Sartori L, Pennuto M, Gaiani A, Bello L, Semplicini C, Pareyson D, Silani V, Ermani M, Ferlin A, Sorarù G, Italian Study Group on Kennedy’s disease (2015) Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients. J Neurol Neurosurg Psychiatry. doi:10.​1136/​jnnp-2015-311305 PubMedCentral
27.
go back to reference Pareyson D, Fratta P, Pradat PF, Sorarù G, Finsterer J, Vissing J, Jokela ME, Udd B, Ludolph AC, Sagnelli A, Weydt P (2016) Towards a European registry and biorepository for patients with spinal and bulbar muscular atrophy. J Mol Neurosci. doi:10.1007/s12031-015-0704-5 Pareyson D, Fratta P, Pradat PF, Sorarù G, Finsterer J, Vissing J, Jokela ME, Udd B, Ludolph AC, Sagnelli A, Weydt P (2016) Towards a European registry and biorepository for patients with spinal and bulbar muscular atrophy. J Mol Neurosci. doi:10.​1007/​s12031-015-0704-5
Metadata
Title
Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure
Authors
Giorgia Querin
Elisa DaRe
Ilaria Martinelli
Luca Bello
Cinzia Bertolin
Davide Pareyson
Caterina Mariotti
Elena Pegoraro
Gianni Sorarù
Publication date
01-11-2016
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 11/2016
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-016-2666-y

Other articles of this Issue 11/2016

Neurological Sciences 11/2016 Go to the issue